Sensus Healthcare revenue plunges 59% as gross margin collapses to 29%; tax asset risk emerges

Filed May 13, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 15, 2025 · ~1 min read

Key Changes

• high

  Revenue fell 59% to $3.4M in Q1 2026 (vs. 22% decline prior year) on just 10 unit sales versus 21 a year earlier, with no sales to historically large customer. Operating loss widened to $4.4M from $2.6M.

  MD&A: Revenue & Operations verify on EDGAR →
• high

  Gross margin collapsed to 29.4% from 53.0%, driven by higher international shipments at lower prices and upfront costs for new Fair Deal Agreement placements where revenue is recognized over time rather than at shipment.

  MD&A: Gross Margin verify on EDGAR →
• high

  Management warns that continued revenue declines could force a valuation allowance against deferred tax assets, materially affecting results—a new risk not disclosed in prior-year filing.

  MD&A: Income Taxes verify on EDGAR →